Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chugai Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥11.18T | 28.8x | 1.56 | ¥6,785 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
Takeda Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥7.01T | 33.7x | 2.21 | ¥4,448 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.7% Upside | Upgrade to Pro+ | |
Daiichi Sankyo | Tokyo | Healthcare | Pharmaceuticals | ¥6.49T | 26.8x | 0.81 | ¥3,463 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Otsuka Holdings Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥4.02T | 11.8x | 0.06 | ¥7,510 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ | |
Astellas Pharma Inc. | Tokyo | Healthcare | Pharmaceuticals | ¥2.59T | -45.2x | 0.03 | ¥1,446 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37% Upside | Upgrade to Pro+ | |
Shionogi | Tokyo | Healthcare | Pharmaceuticals | ¥1.94T | 11.5x | 0.93 | ¥2,284.50 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
Eisai | Tokyo | Healthcare | Pharmaceuticals | ¥1.2T | 20.7x | 0.67 | ¥4,270 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | |
Kyowa Kirin | Tokyo | Healthcare | Pharmaceuticals | ¥1.17T | 19.7x | -0.77 | ¥2,223.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
Ono Pharmaceutical Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥817.29B | 11.1x | -0.26 | ¥1,735.50 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1% Downside | Upgrade to Pro+ | |
Rohto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥496.78B | 16.9x | -3.89 | ¥2,195 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipal Holdings Corp | Tokyo | Healthcare | Pharmaceuticals | ¥473.5B | 9.6x | 0.28 | ¥2,274 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Santen Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥466.69B | 17.9x | 4.71 | ¥1,394 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.7% Upside | Upgrade to Pro+ | |
Suzuken Co Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥350.01B | 10.9x | 0.33 | ¥4,832 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.2% Upside | Upgrade to Pro+ | |
Tsumura & Co | Tokyo | Healthcare | Pharmaceuticals | ¥322.37B | 11.9x | 0.19 | ¥4,246 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.5% Upside | Upgrade to Pro+ | |
Hisamitsu Pharmaceutical Inc | Tokyo | Healthcare | Pharmaceuticals | ¥298.23B | 19.6x | 1.47 | ¥4,080 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.3% Upside | Upgrade to Pro+ | |
Sumitomo Dainippon Pharma | Tokyo | Healthcare | Pharmaceuticals | ¥275.32B | -1.6x | 1.2 | ¥695 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.4% Downside | Upgrade to Pro+ | |
Nippon Shinyaku | Tokyo | Healthcare | Pharmaceuticals | ¥265.4B | 8.7x | 0.34 | ¥3,947 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.9% Downside | Upgrade to Pro+ | |
Toho Holdings | Tokyo | Healthcare | Pharmaceuticals | ¥263.62B | 15.1x | 8.14 | ¥4,172 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7% Upside | Upgrade to Pro+ | |
Sawai Group Holdings Co | Tokyo | Healthcare | Pharmaceuticals | ¥235.87B | 10.2x | 0.22 | ¥2,045 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Kaken Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥179.26B | 8.7x | 0.02 | ¥4,749 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
Kissei Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥154.95B | 13.6x | -22.03 | ¥3,620 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
Towa Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥133.11B | 6.9x | 0.11 | ¥2,712 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33% Upside | Upgrade to Pro+ | |
Torii Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥122.54B | 24.4x | 1.11 | ¥4,395 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
Mochida Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥117.52B | 20.6x | 0.22 | ¥3,300 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zeria Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥96.75B | 12.8x | -1.01 | ¥2,192 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kyorin Holdings Inc | Tokyo | Healthcare | Pharmaceuticals | ¥91.57B | 23.8x | -2.42 | ¥1,600 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17.5% Downside | Upgrade to Pro+ | |
Nxera Pharma | Tokyo | Healthcare | Pharmaceuticals | ¥75.88B | -15.6x | -0.41 | ¥842 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Katakura Industries | Tokyo | Healthcare | Pharmaceuticals | ¥72.51B | 20.8x | 1.26 | ¥2,260 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ASKA Pharmaceutical Holdings Co | Tokyo | Healthcare | Pharmaceuticals | ¥64.05B | 12.3x | -0.59 | ¥2,265 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.2% Upside | Upgrade to Pro+ | |
JCR Pharmaceuticals | Tokyo | Healthcare | Pharmaceuticals | ¥61.52B | -273.9x | 2.59 | ¥506 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27% Upside | Upgrade to Pro+ | |
Vital Ksk Holdings | Tokyo | Healthcare | Pharmaceuticals | ¥57.69B | 8.2x | 15.15 | ¥1,190 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cuorips | Tokyo | Healthcare | Pharmaceuticals | ¥50.08B | -64.3x | 9.69 | ¥7,080 | 13.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seikagaku Corp | Tokyo | Healthcare | Pharmaceuticals | ¥42.63B | 16.6x | 0.17 | ¥785 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fuji Pharma Co Ltd | Tokyo | Healthcare | Pharmaceuticals | ¥32.67B | 7.4x | -0.57 | ¥1,343 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daito Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥31.81B | 12.2x | -0.62 | ¥2,088 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
Koa Shoji | Tokyo | Healthcare | Pharmaceuticals | ¥29.69B | 8.4x | 0.54 | ¥704 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fuso Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥21.23B | 4.6x | ¥2,504 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
StemRIM | Tokyo | Healthcare | Pharmaceuticals | ¥21.1B | 0.01 | ¥338 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CanBas | Tokyo | Healthcare | Pharmaceuticals | ¥18.67B | -13.8x | 1.42 | ¥978 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astena Holdings | Tokyo | Healthcare | Pharmaceuticals | ¥17.63B | -6.9x | 0.02 | ¥437 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncolys Biopharma | Tokyo | Healthcare | Pharmaceuticals | ¥17.1B | -8.9x | -0.35 | ¥694 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ReproCell | Tokyo | Healthcare | Pharmaceuticals | ¥15.55B | -136.4x | -2.64 | ¥166 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiko Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥14.2B | 15.8x | 0.13 | ¥282 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stella Pharma | Tokyo | Healthcare | Pharmaceuticals | ¥13.65B | -24.6x | -1.13 | ¥387 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CellSeed | Tokyo | Healthcare | Pharmaceuticals | ¥13.49B | -7.8x | ¥388 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Renascience | Tokyo | Healthcare | Pharmaceuticals | ¥12.79B | 164.3x | 0.85 | ¥951 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ohki Healthcare | Tokyo | Healthcare | Pharmaceuticals | ¥11.24B | 4.8x | 11.53 | ¥824 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Harima-Kyowa | Tokyo | Healthcare | Pharmaceuticals | ¥10.56B | 7.2x | 0.97 | ¥1,970 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Perseus Proteomics | Tokyo | Healthcare | Pharmaceuticals | ¥10.22B | -0.36 | ¥720 | 3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Wakamoto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | ¥9.85B | -33.7x | ¥282 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |